These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8614841)

  • 21. The Importance of Applying ACOSOG Z0011 Criteria in the Axillary Management of Invasive Lobular Carcinoma: A Multi-institutional Cohort Study.
    Roberts A; Nofech-Mozes S; Youngson B; McCready DR; Al-Assi M; Ramkumar S; Cil T
    Ann Surg Oncol; 2015 Oct; 22(10):3397-401. PubMed ID: 26215196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Axillary regional recurrence after sentinel lymph node biopsy for breast cancer.
    Rosing DK; Dauphine CE; Vargas MP; Gonzalez K; Burla M; Kaufmann P; Vargas HI
    Am Surg; 2006 Oct; 72(10):939-42. PubMed ID: 17058740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of ACOSOG Z0011 criteria reduces perioperative costs.
    Camp MS; Greenup RA; Taghian A; Coopey SB; Specht M; Gadd M; Hughes K; Smith BL
    Ann Surg Oncol; 2013 Mar; 20(3):836-41. PubMed ID: 23010735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minimally invasive operation for breast cancer.
    Singletary SE; Dowlatshahi K; Dooley W; Hollenbeck ST; Kern K; Kuerer H; Newman LA; Simmons R; Whitworth P
    Curr Probl Surg; 2004 Apr; 41(4):394-447. PubMed ID: 15114298
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of ductal carcinoma in situ: an uncertain harm-benefit balance.
    Prescrire Int; 2013 Dec; 22(144):298-303. PubMed ID: 24600734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical management of invasive breast cancer: a 5-year prospective study of treatment in the Australian Capital Territory and South-Eastern New South Wales.
    Koshy A; Buckingham JM; Zhang Y; Craft P; Dahlstrom JE; Tait N;
    ANZ J Surg; 2005 Sep; 75(9):757-61. PubMed ID: 16173988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Omission of axillary lymph node dissection for clinically node negative early-stage breast cancer patients.
    Kobayashi R; Shiraishi K; Iwase S; Ohtomo K; Nakagawa K
    Breast Cancer; 2015 Nov; 22(6):657-63. PubMed ID: 24756246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Invasive breast cancer. Surgical treatment alternatives.
    Marchant DJ
    Obstet Gynecol Clin North Am; 1994 Dec; 21(4):659-79. PubMed ID: 7731640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The feasibility of sentinel node biopsy in the previously treated breast.
    Koizumi M; Koyama M; Tada K; Nishimura S; Miyagi Y; Makita M; Yoshimoto M; Iwase T; Horii R; Akiyama F; Saga T
    Eur J Surg Oncol; 2008 Apr; 34(4):365-8. PubMed ID: 17532172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The sentinel lymph node procedure also feasible in patients with recurrent breast cancer].
    Roumen RM; Kuijt GP; Liem LH
    Ned Tijdschr Geneeskd; 2008 Jan; 152(1):13-9. PubMed ID: 18240754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Breast cancer: axillary dissection--or an unnecessary procedure?].
    Schäfer P
    Schweiz Med Wochenschr; 1998 Oct; 128(43):1667-74. PubMed ID: 9842666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breast cancer in older women: screening and selection of locoregional therapy.
    Sener SF
    Semin Surg Oncol; 1996; 12(5):328-31. PubMed ID: 8873320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Minimally invasive surgery for breast cancer].
    Sawai K; Nakajima H; Mizuta N; Sakaguchi K; Hachimine T
    Gan To Kagaku Ryoho; 2001 Aug; 28(8):1063-70. PubMed ID: 11525019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
    Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
    J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Management of the axilla in breast cancer: evidences and unresolved issues].
    Fodor J; Polgár C; Péley G; Németh G
    Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conservative axillary surgery in breast cancer patients undergoing mastectomy: long-term results.
    Cowher MS; Grobmyer SR; Lyons J; O'Rourke C; Baynes D; Crowe JP
    J Am Coll Surg; 2014 Apr; 218(4):819-24. PubMed ID: 24655877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Axillary node staging for microinvasive breast cancer: is it justified?
    Lyons JM; Stempel M; Van Zee KJ; Cody HS
    Ann Surg Oncol; 2012 Oct; 19(11):3416-21. PubMed ID: 22576061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sentinel lymph node biopsy, axillary dissection and breast cancer: radiation oncologist's viewpoint.
    Bansal M; Mohanti BK
    Natl Med J India; 2002; 15(3):154-7. PubMed ID: 12186329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Local relapse in young (< or = 40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results].
    Fodor J; Mózsa E; Zaka Z; Polgár C; Major T
    Magy Onkol; 2005; 49(3):203, 205-8. PubMed ID: 16249814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.